- Governance principles
- General Meeting
- Annual General Meeting 2025
- Board of Directors
- Management Team
- Remuneration
- Risk management
- Insider management
- Managers' transactions
- Flagging notifications
- Auditor
- Articles of Association
- Code of Conduct
- Stock Exchange Releases
- Company releases
- Press releases
- Managers' transactions
- Flagging notifications
- En
- Fi
Welcome to Nightingale Health's investor pages
On our investor pages, you can read about Nightingale Health as an investment, find our latest releases and reports as well as follow Nightingale Health's share price development.
About Nightingale Health
Nightingale Health’s mission is to build sustainable healthcare and reduce health inequalities. Nightingale Health has developed the world’s most advanced health check for the health industry. Our solution provides risk detection for multiple chronic diseases from a single blood sample.
Nightingale Health Check can be scaled to entire populations at a low cost, and it can replace many of the current risk assessments. Detecting disease risks on a population level allows for the effective targeting and tracking of health interventions, and better prevention of the onset of chronic diseases.
Contact us
ir@nightingalehealth.com
Half-year report 1 July - 31 December 2024 has been published
Latest releases
Nightingale Health's half-year report: International expansion continues in Southeast Asia and the United States
Nightingale Health to publish half-year report for July - December 2024 on 6 March 2025
Nightingale Health and Enigma Genomics enter into collaboration to sell the Nightingale Remote Health Check in the MENA region
Resolutions of the Annual General Meeting and the Board of Directors’ organizational meeting of Nightingale Health Plc
Subscribe to releases.
Get the latest Nightingale Health releases delivered straight to your inbox.